|
Microorganism
|
Bile
|
Draina
|
|---|
|
Patients
|
CEF resb
|
AMP resc
|
P valued
|
Patients
|
CEF resb
|
AMP resc
|
P valued
|
|---|
|
N (%)
|
%
|
%
| |
N (%)
|
(%)
|
(%)
|
|---|
|
Enterococcus spp.
|
79 (74.5)
|
100
|
13.9
|
<0.001
|
67 (69.1)
|
100
|
28.9
|
<0.001
|
|
Escherichia coli
|
39 (36.8)
|
59
|
41
|
<0.113
|
26 (26.8)
|
76.9
|
57.7
|
<0.139
|
|
Klebsiella spp.
|
37 (34.9)
|
35.1
|
21.6
|
0.197
|
18 (18.6)
|
72.2
|
50
|
0.171
|
|
Enterobacter spp.
|
19 (17.9)
|
94.7
|
94.7
|
1.000
|
24 (24.7)
|
95.8
|
100
|
0.312
|
|
Citrobacter spp.
|
10 (9.4)
|
80
|
80
|
-
|
6 (6.2)
|
100
|
83.3
|
-
|
|
Hafnia alvei
|
7 (6.6)
|
71.4
|
100
|
-
|
3 (3.1)
|
100
|
100
|
-
|
|
Staphylococcus spp.
|
5 (4.7)
|
40
|
40
|
-
|
26 (26.8)
|
73.1
|
92.3
|
0.067
|
|
Pseudomonas aeruginosa
|
4 (3.8)
|
100
|
100
|
-
|
8 (8.3)
|
100
|
100
|
-
|
|
Aeromonas spp.
|
3 (2.8)
|
66.7
|
33.3
|
-
|
0
|
/
|
/
|
-
|
|
Serratia Marcescens
|
2 (1.9)
|
100
|
100
|
-
|
4 (4.1)
|
100
|
100
|
-
|
|
Streptococcus spp.
|
2 (1.9)
|
100
|
50
|
-
|
3 (3.1)
|
66.7
|
0
|
-
|
|
Morganella morganii
|
1 (0.9)
|
100
|
100
|
-
|
2 (2.1)
|
100
|
100
|
-
|
|
Proteus spp.
|
1 (0.9)
|
100
|
100
|
-
|
2 (2.1)
|
100
|
50
|
-
|
|
Candida spp.
|
9 (8.5)
|
/
|
/
|
/
|
21 (21.7)
|
/
|
/
|
/
|
-
aDrains with positive culture (surgical and percutaneous)
-
bCefazolin resistance
-
cAmpicillin-sulbactam resistance
-
dCorrelation between cefazolin resistance and Ampicillin-sulbactam resistance
- - Data were not compared due to the small sample size;/Not evaluable
